News | Radiopharmaceuticals and Tracers | March 14, 2019

Researchers Create New Method for Developing Cancer Imaging Isotopes

New method produces high-purity zirconium-89, a diagnostic radionuclide used to image cancerous tumors

Researchers Create New Method for Developing Cancer Imaging Isotopes

Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory

March 14, 2019 — A team of researchers at the University of Washington announced they developed a new automated system for producing zirconium-89, a diagnostic radionuclide used for cancer tumor imaging.

Ideal for cancer tumor imaging, zirconium-89 lasts long enough in the body to find tumors and be imaged using positron emission tomography (PET) scans. Producing this useful radionuclide requires commonly found low-energy cyclotrons. The researchers produced zirconium-89 by proton beam irradiation of yttrium metal foils at the university’s 11-MeV cyclotron. They then transported the foils to researchers at the Pacific Northwest National Laboratory. The research team developed an automated dual column system that dissolved the foil targets and isolated the zirconium-89 from the dissolved yttrium target (and metal contaminants found in the yttrium metal). The process consistently generated a highly concentrated and pure solution of zirconium-89 that demonstrated excellent binding to deferoxamine, a radionuclide-binding ligand frequently used in tumor-targeting molecules. A patent has been applied for this novel purification method.

As the zirconium-89 supply is currently meeting demand, this is not an isotope sold through the U.S. Department of Energy (DOE) Isotope Program. However, this work, supported by the DOE Isotope Program, shows that zirconium-89 can be produced on lower energy (and more abundant) cyclotrons with a simple target design. The new automated approach could make high-quality batches more available and reduce exposure for radiation workers. Also, the approach offers a high chemical yield and low metal ion impurities, minimizing interference with tumor targeting.

This work was funded by the Department of Energy, Office of Science, Office of Nuclear Physics, Isotope Development and Production for Research and Applications subprogram. Funding was also provided by the National Institutes of Health. The researchers used the CT/Eclipse/111 cyclotron at the University of Washington.

For more information: www.science.energy.gov

Publications

J.M. Link, K.A. Krohn, and M.J. O’Hara, “A simple thick target for production of 89Zr using an 11MeV cyclotron.” Applied Radiation and Isotopes 122, 211 (2017). [DOI: 10.1016/j.apradiso.2017.01.037]

M.J. O’Hara, N.J. Murray, J.C. Carter, C.M. Kellogg, and J.M. Link, “Hydroxamate column-based purification of zirconium-89 (89Zr) using an automated fluidic platform.” Applied Radiation and Isotopes 132, 85 (2018). [DOI: 10.1016/j.apradiso.2017.10.048]

M.J. O’Hara, N.J. Murray, J.C. Carter, and S.S. Morrison, “Optimized anion exchange column isolation of zirconium-89 (89Zr) from yttrium cyclotron target: Method development and implementation on an automated fluidic platform.” Journal of Chromatography A 1545, 48 (2018). [DOI: 10.1016/j.chroma.2018.02.053]

M.J. O’Hara, N.J. Murray, J.C. Carter, C.M. Kellogg, and J.M. Link, “Tandem column isolation of zirconium-89 from cyclotron bombarded yttrium targets using an automated fluidic platform: Anion exchange to hydroxamate resin columns.” Journal of Chromatography A 1567, 37 (2018). [DOI: 10.1016/j.chroma.2018.06.035]

Related Content

GE Healthcare and Premier Inc. Developing One-stop Breast Clinic Model for U.S.
News | Mammography | October 21, 2019
GE Healthcare and Premier Inc. have announced a collaboration to develop a model to bring a same-day breast cancer...
GE Healthcare and Theragnostics Partnering on PSMA PET/CT Imaging Agent
News | Prostate Cancer | October 16, 2019
GE Healthcare and Theragnostics have entered into a global commercial partnership for a new prostate-specific membrane...
University of Arizona to Develop New CT-Based Breast Cancer Diagnostic Imaging Method
News | Breast Imaging | September 27, 2019
Researchers at the University of Arizona Health Sciences are seeking a new and more accurate way to diagnose breast...
Numerical simulation with a heterogeneous mouse

Numerical simulation with a heterogeneous mouse. (a) The geometry of the mouse with major organs near the source, and (b) the surface fluence computed with TIM-OS. Image courtesy of Rensselaer Polytechnic Institute.

News | Oncology Diagnostics | September 20, 2019
If researchers could observe drug delivery and its effect on cancer cells in real time, they would be able to tailor...
Screening Mammography Could Benefit Men at High Risk of Breast Cancer
News | Mammography | September 18, 2019
Selective mammography screening can provide potentially lifesaving early detection of breast cancer in men who are at...
iCAD's ProFound AI Wins Best New Radiology Solution in 2019 MedTech Breakthrough Awards
News | Computer-Aided Detection Software | September 09, 2019
iCAD Inc. announced MedTech Breakthrough, an independent organization that recognizes the top companies and solutions...
Imaging Biometrics and Medical College of Wisconsin Awarded NIH Grant
News | Neuro Imaging | September 09, 2019
Imaging Biometrics LLC (IB), in collaboration with the Medical College of Wisconsin (MCW), has received a $2.75 million...
ASNC Announces Multisocietal Cardiac Amyloidosis Imaging Consensus
News | Cardiac Imaging | September 09, 2019
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along
A 3-D printed tungsten pre-clinical X-ray system collimator. 3D printed, additive manufacturing for medical imaging.

A 3-D printed tungsten pre-clinical X-ray system collimator. The tungsten alloy powder is printed into the form desired and is laser fused so it can be machined and finished. Previously, making collimators from Tungsten was labor intensive because it required working with sheets of the metal to create the collimator matrix. 

Feature | Medical 3-D Printing | September 04, 2019 | By Steve Jeffery
In ...